Beranda › Kanker Hati
Uji klinis Kanker Hati yang merekrut di AS
67 studi untuk Kanker Hati merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX14 studi
- Los Angeles, CA11 studi
- Cleveland, OH11 studi
- Dallas, TX10 studi
- Boston, MA9 studi
- Chicago, IL8 studi
- St. Louis, MO8 studi
- Philadelphia, PA7 studi
- Durham, NC7 studi
- Washington, DC6 studi
- San Francisco, CA6 studi
- Orange, CA6 studi
- New York City, NY6 studi
- Nashville, TN5 studi
- Baldwin Park, CA5 studi
- Seattle, WA5 studi
- Rochester, MN5 studi
- Pittsburgh, PA5 studi
- San Diego, CA4 studi
- Mountain View, CA4 studi
- Ann Arbor, MI4 studi
- Aurora, CO4 studi
- Birmingham, AL3 studi
- The Bronx, NY3 studi
- Portland, OR3 studi
- Winston-Salem, NC3 studi
- Baltimore, MD3 studi
- Omaha, NE3 studi
- Miami, FL3 studi
- Kansas City, MO3 studi
- Tampa, FL3 studi
- Irvine, CA3 studi
- Columbus, OH3 studi
- Atlanta, GA3 studi
- Highlands Ranch, CO3 studi
- Santa Monica, CA3 studi
- Richmond, VA3 studi
- San Antonio, TX3 studi
Berdasarkan negara bagian
- Alabama3 studi
- Arizona5 studi
- Arkansas3 studi
- California24 studi
- Colorado7 studi
- Connecticut3 studi
- Florida10 studi
- Georgia4 studi
- Illinois11 studi
- Kansas3 studi
- Maryland8 studi
- Massachusetts11 studi
- Michigan5 studi
- Minnesota9 studi
- Missouri11 studi
- Nebraska3 studi
- New York10 studi
- North Carolina11 studi
- Ohio15 studi
- Oklahoma3 studi
- Oregon3 studi
- Pennsylvania13 studi
- Tennessee6 studi
- Texas24 studi
- Utah3 studi
- Virginia7 studi
- Washington5 studi
- Wisconsin5 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884Collection of Blood From Patients With Cancer
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00034216Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07227012DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000National Liver Cancer Screening Trial
Menerima pesertaFase 4
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06084234Protoacoustic Imaging For 3D Mapping
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07832617A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06858813A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Menerima peserta
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07824583EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06263088Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07044362Defining the Ablative Dose for Y-90 TARE
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07586046CREO - Microwave Ablation Feasibility Study
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07817147Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Menerima pesertaStudi observasional
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06486454GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT04864054A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06440005Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Menerima pesertaStudi observasional
Usia 18 hingga 50 · Wanita · Diperbarui 2 Sep 2026 · NCT06904365Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05517811HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06899152Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Menerima pesertaFase 1
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT04715191Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07010315DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT07717437Jump: MR Simulation For Radiation Therapy Master Protocol
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT04545957Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06580002Multi-analyte Blood Test Clinical Trial
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT05199259A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07337525Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.